Search Results - "GONZALEZ DE REQUENA, Daniel"

Prediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotient by González de Requena, Daniel, Gallego, Oscar, Valer, Luisa, Jiménez-Nácher, Inmaculada, Soriano, Vincent

“…The predictive value of virological response to lopinavir (LPV)/ritonavir (r) was assessed in 126 HIV-infected patients who failed antiretroviral therapy and…”
Get more information

Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment by D'AVOLIO, Antonio, CIANCIO, Alessia, GONZALEZ DE REQUENA, Daniel, SCIANDRA, Mauro, TROSHINA, Giulia, CAVIGLIA, Gian Paolo, BONORA, Stefano, RIZZETTO, Mario, DI PERRI, Giovanni, SICCARDI, Marco, SMEDILE, Antonina, SIMIELE, Marco, CUSATO, Jessica, BAIETTO, Lorena, AGUILAR MARUCCO, Diego, CARITI, Giuseppe, CALCAGNO, Andrea

“…The response rate to treatment of chronic hepatitis C virus-genotype 1 and 4 infections was recently found to be strongly influenced by many polymorphisms. The…”
Get full text

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients by D'AVOLIO, Antonio, SCIANDRA, Mauro, GONZALEZ DE REQUENA, Daniel, IBANEZ, Allende, BONORA, Stefano, DI PERRI, Giovanni

“…An improved HPLC fluorimetric method for the quantification of enfuvirtide in plasma of HIV-infected subjects was described and validated. The use of an…”
Get full text

Analyzing Sleep Abnormalities in HIV-Infected Patients Treated with Efavirenz by Gallego, Lucía, Barreiro, Pablo, del Río, Rafael, González deRequena, Daniel, Rodríguez-Albariñ, Apolinar, González-Lahoz, Juan, Soriano, Vincent

“…Ambulatory electroencephalogram monitoring was performed for 18 HIV-infected subjects treated with efavirenz with and without insomnia and for 13 healthy…”
Get full text

Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation by Bonora, Stefano, Nicastri, Emanuele, Calcagno, Andrea, Gonzalez de Requena, Daniel, D'Ettorre, Gabriella, Sarmati, Loredana, Palmisano, Lucia, Vullo, Vincenzo, Di Perri, Giovanni, Andreoni, Massimo

“…Improvements in HIV-RNA assays have made accurate detection of as few as 2 copies/ml possible. This study objective was the evaluation of ultrasensitive…”
Get full text

Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients by D’Avolio, Antonio, Ibañez, Allende, Sciandra, Mauro, Siccardi, Marco, de Requena, Daniel Gonzalez, Bonora, Stefano, Di Perri, Giovanni

“…Measurement of ribavirin plasma levels in HCV-positive patients have been shown to be useful in order to optimise individual ribavirin exposure. Efficacy and…”
Get full text

Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients by Calcagno, Andrea, Nozza, Silvia, Gonzalez de Requena, Daniel, Galli, Andrea, D'Avolio, Antonio, Simiele, Marco, Chiappetta, Stefania, Di Perri, Giovanni, Lazzarin, Adriano, Bonora, Stefano

Get full text

Inosine Triphosphatase Polymorphisms and Ribavirin Pharmacokinetics as Determinants of Ribavirin-Associate Anemia in Patients Receiving Standard Anti-HCV Treatment by D'AVOLIO, Antonio, CIANCIO, Alessia, SCIANDRA, Mauro, CUSATO, Jessica, TROSHINA, Giulia, BONORA, Stefano, RIZZETTO, Mario, DI PERRI, Giovanni, SICCARDI, Marco, SMEDILE, Antonina, BAIETTO, Lorena, SIMIELE, Marco, AGUILAR MARUCCO, Diego, CARITI, Giuseppe, CALCAGNO, Andrea, DE REQUENA, Daniel Gonzalez

“…Functional variants of inosine triphosphatase (ITPA) were recently found to protect against ribavirin (RBV)-induced hemolytic anemia. However, no definitive…”
Get full text

Raltegravir Penetration in Seminal Plasma of Healthy Volunteers by CALCAGNO, Andrea, BONORA, Stefano, D'AVOLIO, Antonio, SICCARDI, Marco, SIMIELE, Marco, CHIESA, Mattia, GONZALEZ DE REQUENA, Daniel, DI PERRI, Giovanni

Get full text

Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens by Valer, Luisa, González de Requena, Daniel, de Mendoza, Carmen, Martin-Carbonero, Luz, González-Lahoz, Juan, Soriano, Vincent

“…Coadministration of amprenavir (APV) with small doses of ritonavir (RTV) results in a significant increase in APV plasma concentrations. Viruses showing…”
Get more information

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination by Calcagno, Andrea, Nozza, Silvia, Bonora, Stefano, Castagna, Antonella, Gonzalez de Requena, Daniel, D'Avolio, Antonio, Lazzarin, Adriano, Di Perri, Giovanni

Get full text

Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens by GONZALEZ DE REQUENA, Daniel, BONORA, Stefano, VITIELLO, Paola, GALLI, Massimo, RUSCONI, Stefano, DI PERRI, Giovanni, VIGANO, Ottavia, CALCAGNO, Andrea, COMETTO, Cristina, D'AVOLIO, Antonio, BAIETTO, Lorena, GHISETTI, Valeria, MAGNANI, Silvia, FERRAMOSCA, Stefania

“…the darunavir genotypic inhibitory quotient (gIQ) has been suggested as one of the predictors of virological response to darunavir-containing salvage regimens…”
Get full text

Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients by Bonora, Stefano, Gonzalez de Requena, Daniel, D'Avolio, Antonio, Calcagno, Andrea, Tettoni, Mariacristina, Siccardi, Marco, Baietto, Lorena, Simiele, Marco, Trentini, Laura, Di Perri, Giovanni

“…Use of unboosted atazanavir (ATV) with tenofovir disoproxil fumarate (TDF), although attractive from a clinical view point, has not been tested in trials and…”
Get more information

A New Assay Based on Solid-Phase Extraction Procedure with LC-MS to Measure Plasmatic Concentrations of Tenofovir and Emtricitabine in HIV Infected Patients by D'Avolio, Antonio, Sciandra, Mauro, Siccardi, Marco, Baietto, Lorena, de Requena, Daniel Gonzalez, Bonora, Stefano, Di Perri, Giovanni

“…A new solid-phase extraction (SPE) method has been developed and validated on a liquid chromatography (LC) coupled with a mass spectrometer for the…”
Get full text

Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide by DE REQUENA, Daniel Gonzalez, CALCAGNO, Andrea, BONORA, Stefano, LADETTO, Laura, D'AVOLIO, Antonio, SCIANDRA, Mauro, SICCARDI, Marco, BARGIACCHI, Olivia, SINICCO, Alessandro, DI PERRI, Giovanni

“…Fifty-five patients placed on tipranavir/ritonavir 500/200 mg twice a day (27 with enfuvirtide and 28 without) underwent tipranavir and ritonavir plasma…”
Get full text

Tipranavir (TPV) Genotypic Inhibitory Quotient Predicts Virological Response at 48 Weeks to TPV-Based Salvage Regimens by DE REQUENA, Daniel Gonzalez, BONORA, Stefano, BAIETTO, Lorena, TRENTINI, Laura, DI PERRI, Giovanni, CALCAGNO, Andrea, D'AVOLIO, Antonio, SICCARDI, Marco, FONTANA, Silvia, GRAZIA MILIA, Maria, SCIANDRA, Mauro, GARAZZINO, Silvia, DI GARBO, Antonio

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Liver toxicity caused by nevirapine by GONZALEZ DE REQUENA, Daniel, NUNEZ, Marina, JIMENEZ-NACHER, Inmaculada, SORIANO, Vincent

“…Nevirapine plasma levels were measured in 70 HIV-infected patients, 33 of whom developed transaminase elevations. Higher nevirapine levels and hepatitis C…”
Get full text

Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir by González de Requena, Daniel, Blanco, Francisco, Garcia-Benayas, Teresa, Jiménez-Nácher, Inmaculada, González-Lahoz, Juan, Soriano, Vincent

“…Lopinavir (LPV)/ritonavir (RTV) used in combination, is a potent antiretroviral drug. However, its benefit is limited by its inherent effect on lipid…”
Get more information

A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method by D’Avolio, Antonio, Sciandra, Mauro, Siccardi, Marco, Baietto, Lorena, de Requena, Daniel Gonzalez, Bonora, Stefano, Di Perri, Giovanni

“…A simple method for the quantification of tipranavir, the first non-peptidic HIV protease inhibitor, was developed and validated. Quinoxaline, as internal…”
Get full text

Does Iatrogenic Scleroderma due to Injection-Site Reaction to Enfuvirtide Impair Absorption of the Drug? by Maggi, Paolo, Filotico, Raffaele, Bonora, Stefano, Volpe, Anna, Bellacosa, Chiara, Cinori, Eliana, de Requena, Daniel Gonzalez, D’Avolio, Antonio, Di Perri, Giovanni

“…Background: Chronic iatrogenic scleroderma is a possible obstacle to the absorption of subcutaneously administered drugs. This study correlated the clinical…”
Get full text